UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

Journal of Virology, 2011-01, Vol.85 (1), p.366-377

2011

Volltextzugriff (PDF)

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Clinical Microbiology Reviews, 2005-07, Vol.18 (3), p.541-555

2005

Volltextzugriff (PDF)

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.996-1002

2011

Volltextzugriff (PDF)

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Journal of Virology, 2012-05, Vol.86 (10), p.5422-5436

2012

Volltextzugriff (PDF)

Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector

Journal of Virology, 2006-02, Vol.80 (3), p.1130-1139

2006

Volltextzugriff (PDF)

Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus

The Journal of infectious diseases, 2013-07, Vol.208 (2), p.319-329

2013

Volltextzugriff (PDF)

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

Vaccine, 2013-04, Vol.31 (17), p.2169-2176

2013

Volltextzugriff (PDF)

Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins

Antiviral research, 2014-11, Vol.111, p.129-135

2014

Volltextzugriff (PDF)

Interleukin 18 Coexpression during Respiratory Syncytial Virus Infection Results in Enhanced Disease Mediated by Natural Killer Cells

Journal of Virology, 2010-04, Vol.84 (8), p.4073-4082

2010

Volltextzugriff (PDF)

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

Vaccine, 2007-10, Vol.25 (42), p.7372-7378

2007

Volltextzugriff (PDF)

Innate Immune Dysfunction is Associated with Enhanced Disease Severity In Infants with Severe Respiratory Syncytial Virus Bronchiolitis

The Journal of infectious diseases, 2013-02, Vol.207 (4), p.564-573

2013

Volltextzugriff (PDF)

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases

The Pediatric infectious disease journal, 2008-10, Vol.27 (10 Suppl), p.S92-S96

2008

Volltextzugriff (PDF)

Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus

The Journal of infectious diseases, 2008-10, Vol.198 (7), p.1007-1015

2008

Volltextzugriff (PDF)

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

Journal of allergy and clinical immunology, 2012-11, Vol.130 (5), p.1187-1196.e5

2012

Volltextzugriff (PDF)

Do early-life viral infections cause asthma?

Journal of allergy and clinical immunology, 2010-06, Vol.125 (6), p.1202-1205

2010

Volltextzugriff (PDF)

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

Vaccine, 2009-09, Vol.27 (42), p.5913-5919

2009

Volltextzugriff (PDF)

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation

Vaccine, 2010-08, Vol.28 (34), p.5543-5550

2010

Volltextzugriff (PDF)

Response to infections in patients with asthma and atopic disease: An epiphenomenon or reflection of host susceptibility?

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.343-351

2012

Volltextzugriff (PDF)

Delivery of Cytokines by Recombinant Virus in Early Life Alters the Immune Response to Adult Lung Infection

Journal of Virology, 2010-05, Vol.84 (10), p.5294-5302

2010

Volltextzugriff (PDF)

Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection

Journal of Virology, 2012-02, Vol.86 (4), p.2251-2258

2012

Volltextzugriff (PDF)

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Journal of allergy and clinical immunology, 2005-10, Vol.116 (4), p.805-811

2005

Volltextzugriff (PDF)

Circulating Antibody-Secreting Cells during Acute Respiratory Syncytial Virus Infection in Adults

The Journal of infectious diseases, 2010-12, Vol.202 (11), p.1659-1666

2010

Volltextzugriff (PDF)

Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime–protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology

Vaccine, 2008-09, Vol.26 (37), p.4840-4848

2008

Volltextzugriff (PDF)

Resveratrol-Mediated Gamma Interferon Reduction Prevents Airway Inflammation and Airway Hyperresponsiveness in Respiratory Syncytial Virus-Infected Immunocompromised Mice

Journal of Virology, 2011-12, Vol.85 (24), p.13061-13068

2011

Volltextzugriff (PDF)

Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats

Journal of Virology, 2007-12, Vol.81 (24), p.13710-13722

2007

Volltextzugriff (PDF)

1 – 25 von 1.944

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.909)
Mit Volltextzugriff
(1.511)

Publikationsform

Artikel
(1.941)
Tagungsberichte
(3)

Sprache

Englisch
(1.944)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.801)
Life Sciences & Biomedicine
(1.790)
Humans
(1.472)
Medical Sciences
(1.276)
Respiratory Syncytial Virus
(1.266)
Infectious Diseases
(1.067)
Immunology
(1.025)
Fundamental And Applied Biological Sciences. Psychology
(1.009)
Microbiology
(985)
Female
(805)
Viral Diseases
(787)
Virology
(783)
Infant
(750)
Respiratory Syncytial Viruses - Immunology
(722)
Animals
(719)
Human Viral Diseases
(665)
Male
(619)
Viral Diseases Of The Respiratory System And Ent Viral Diseases
(577)
Respiratory Syncytial Virus Infections - Immunology
(521)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector

Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins

Interleukin 18 Coexpression during Respiratory Syncytial Virus Infection Results in Enhanced Disease Mediated by Natural Killer Cells

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

Innate Immune Dysfunction is Associated with Enhanced Disease Severity In Infants with Severe Respiratory Syncytial Virus Bronchiolitis

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases

Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

Do early-life viral infections cause asthma?

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation

Response to infections in patients with asthma and atopic disease: An epiphenomenon or reflection of host susceptibility?

Delivery of Cytokines by Recombinant Virus in Early Life Alters the Immune Response to Adult Lung Infection

Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Circulating Antibody-Secreting Cells during Acute Respiratory Syncytial Virus Infection in Adults

Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime–protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology

Resveratrol-Mediated Gamma Interferon Reduction Prevents Airway Inflammation and Airway Hyperresponsiveness in Respiratory Syncytial Virus-Infected Immunocompromised Mice

Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats

Aktive Filter

Suchergebnisse filtern